Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Bolster Your Portfolio with These 3 Pharma Stock Buys

The pharmaceutical industry is booming because of the increasing need for quality healthcare and high-quality medicines, the fast-growing elderly population, and the uptick in chronic illnesses. To capitalize on the industry’s growth prospects, investors could consider buying fundamentally strong pharma stocks Perrigo Company (PRGO), ACADIA Pharmaceuticals (ACAD), and Pacira BioSciences…

StockNews.com

3 Biotech Stocks Making Major Moves on Wall Street

The biotechnology industry is experiencing significant growth, fueled by government initiatives, rising investments and tech advancements. Therefore, it could be wise to consider fundamentally strong biotech stocks Shionogi & Co (SGIOY), Equillium (EQ), and BioMarin Pharmaceutical (BMRN), which are making major moves on wall street. Read more.

StockNews.com

3 Pharma Stocks to Buy for February Gains

The pharmaceutical industry is thriving due to the growing demand for quality healthcare and high-quality drugs, a rapidly aging population, and the rise in chronic diseases. To capitalize on the industry’s growth prospects, investors could consider buying fundamentally strong pharma stocks Amphastar Pharmaceuticals (AMPH), Bausch Health Companies (BHC), and ACADIA…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

This Week's Biotech Stock Star Performers

The biotech industry is poised for robust growth thanks to the increasing demand for personalized treatments, the rise in chronic diseases, a rapidly aging population, the adoption of advanced technologies, and government initiatives. Therefore, to capitalize on the industry’s growth prospects, one could consider buying fundamentally strong biotech stocks Genmab…

StockNews.com

Unleash Gain Potential With 3 Pharma Stocks to Consider

With an increasing demand for treatments of chronic diseases, heightened investments in research and development, and the widespread integration of technology, the pharma industry is primed for success. Amid the solid industry prospects, let’s analyze the gain potential of three pharma stocks: Amneal Pharmaceuticals (AMRX), AbbVie Inc. (ABBV), and GSK…

StockNews.com

Biogen (BIIB): Earnings Alert - Key Insights

Because of its strategic focus on research and therapy improvements for long-term growth, Biogen (BIIB) could come under heat for the mixed outcomes of its recent acquisitions. As stakeholders anticipate the forthcoming earnings release, let's seek insights into the company's future trajectory and implications for BIIB shares. Read on….

StockNews.com

Heavy losses for CSL help drag ASX into the red

The Australian share market has finished down 0.4 per cent in large part because of a failed heart attack drug that CSL spent nearly $1 billion developing.

AAP

Read news from The Economist, FT, and more,
with one subscription

Why Investors Are Flocking to These 2 Medical Stocks

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

StockNews.com

Senate hearings expose pharmaceutical companies amidst rising drug prices

This article discusses a contentious hearing on Capitol Hill where pharmaceutical companies faced scrutiny over high drug prices and their impact on health...

Top News

Novo Holdings Acquires Catalent for .5 Billion, Expands Wegovy Capacity

Novo Holdings has announced its acquisition of Catalent for .5 billion, a move aimed at expanding the production capacity of Wegovy, a drug used for obe...

The Guardian - US

Secretive US rightwing group Alec designs law to give big business ‘complete immunity for bad acts’

Group wrote model legislation to restrict lawsuits under public nuisance laws used to hold opioid makers and others to account

The Guardian - UK

Pharmacies in England and Scotland to offer private Covid jabs – for £45

Pharmadoctor is offering appointments from 1 April for vaccinations and intends to add more pharmacies to its network

StockNews.com

Top 3 Smart Pharma Picks for Good Investments

As global medical needs and technology evolve, the pharmaceutical industry is expected to thrive. Therefore, fundamentally strong pharma stocks Eli Lilly (LLY), AstraZeneca (AZN) and GSK (GSK) might be ideal additions to your portfolio. Read on.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Lucrative Pharma Stocks for Portfolio Success

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

Salon

FTC probe drugmakers’ patent thickets

The Federal Trade Commission has challenged more than 100 patents drugmakers listed in the FDA’s “Orange Book"

StockNews.com

3 B-Rated Pharma Stocks to Secure Now With Great Value

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

International Business Times

Publicis Settles Opioid Case With US States For $350 Mn

Publicis Health will pay $350 million to settle charges from US states that its "predatory and deceptive marketing strategies" worsened the opioid epidemic, New York's top prosecutor said Thursday.

The Guardian - US

Medicare makes opening bid to pharma companies in talks to lower drug costs

Biden administration says public health insurance program has made initial offers for 10 of most commonly used medicines

Salon

Restricting abortion drug access

The Supreme Court will soon decide the fate of access for mifepristone. The fallout of a ban would be tremendous

StockNews.com

AbbVie (ABBV) Earnings Preview: Buy or Sell Opportunities

While AbbVie (ABBV) saw a decrease in net revenues and EPS in the last reported quarter, it raised its 2023 adjusted EPS guidance range. With the company gearing up to report fourth-quarter 2023 results tomorrow, is the stock worth buying today? Keep reading.

1 … 36 37 38 39

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

The Federal Trade Commission

203 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.